Senaste uppdateringen :
19/11/2024
Immunsuppressivum   Tacrolimus  
injektion
ögondroppar Oral lösning
Lösningars stabilitet Stabilitet i blandningar Faktorer som påverkar stabiliteten Kompatibilitet Administreringssätt Hänvisningar pdf
   Molekylstruktur  

Varunamn   Varunamn     

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Prograf Australien, Chile, Colombia, Danmark, Finland, Förenta Staterna, Frankrike, Grekland, Iran, Irland, Italien, Japan, Kanada, Malaysia, Norge, nya Zeeland, Österrike, Polen, Portugal, Rumänien, Schweiz, Spanien, Storbritannien, Sverige, Tyskland, Ungern
Prograft Belgien, Luxemburg, Nederländerna
Hänvisningar   injektion   Hänvisningar : Tacrolimus  
Typ Publikation
207 tidningen Ku YM, Min DI, Kumar V, Noormohamed SE.
Compatibility of tacrolimus injection with cimetidine hydrochloride injection in 0.9% sodium chloride injection.
Am J Health-Syst Pharm 1995 ; 52: 2024-2025.
301 tidningen Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
475 tidningen Taormina D, Abdallah HY, Venkataramanan R, Logue L, Burckart GJ, Ptachcinski RJ, Todo S, Fung JJ, Starzl TE.
Stability and sorption of FK 506 in 5% dextrose injection and 0.9% sodium chloride injection in glass, polyvinyl chloride, and polyolefin containers.
Am J Hosp Pharm 1992 ; 49: 119-122.
479 tidningen Min DI, Brown T, HWang GC.
Visual compatibility of tacrolimus with commonly used drugs during simulated Y-site injection.
Am J Hosp Pharm 1992 ; 49: 2964-2966.
814 tidningen Johnson CE, VandenBussche HL, Chio CC, Jacobson PA.
Stability of tacrolimus with morphine sulfate, hydromorphone hydrochloride, and ceftazidime during simulated intravenous coadministration.
Am J Health-Syst Pharm 1999 ; 56: 164-169.
907 tidningen Ku YM, Min DI, Kumar V, Noormohamed SA.
Stability of tacrolimus injection in total parenteral nutrition solution.
J Pharm Technol 1996 ; 12: 58-61.
1415 tidningen Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1421 tidningen Johnson CE, Truong NM.
Stability and compatibility of tacrolimus and fluconazole in 0.9% sodium chloride.
J Am Pharm Assoc 1999 ; 39: 505-509.
1982 tidningen Trissel LA, Ogundele AB.
Compatibility of anidulafungin with other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2005 ; 62: 834-837.
2108 tidningen Trusley C, Kupiec TC, Trissel LA.
Compatibility of micafungin injection with other drugs during simulated Y-site co-administration.
Int J Pharm Compound 2006 ; 10: 230-232.
2192 tidningen Cochran BG, Sowinski KM, Fausel C, Overholser BR.
Physical compatibility and chemical stability of mycophenolate mofetil during simulated Y-site administration with commonly coadministered drugs.
Am J Health-Syst Pharm 2007 ; 64, 13: 1410-1414.
2247 tidningen Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262 tidningen Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3626 Laboratorium Tacrolimus (Prograf®) - Résumé des Caractéristiques du Produit
Astellas Pharma 2014
3827 affisch Ghazi I.M, Hamada Y, Nicolau D.P.
Compatibility of tedizolid phosphate with selected intravenous drugs via simulated Y-site conditions.
ASHP Midyear 2015
3828 affisch Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 affisch So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
3842 tidningen Lee J.H, Goldspiel B.R, Ryu S, Potti G.K.
Stability of tacrolimus solutions in polyolefin containers.
Am J Health-Syst Pharm 2016 ; 73:137-142.
3915 tidningen Myers A.L, Zhang Y, . Kawedia J.D, Shank B.R, Deaver M.A, Kramer M.A.
Stability of tacrolimus injection diluted in 0.9% sodium chloride injection and stored in Excel bags
Am J Health-Syst Pharm 2016 ; 73,24: 2083-2088.
3948 tidningen Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P .
Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation.
JPEN 2012 ;30. 416?424.
4521 tidningen Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B.
Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit.
Pharmaceutical Technology in Hospital Pharmacy 2020

  Mentions Légales